Your browser doesn't support javascript.
loading
Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
Hernanz, R; Martínez-Revelles, S; Palacios, R; Martín, A; Cachofeiro, V; Aguado, A; García-Redondo, L; Barrús, M T; de Batista, P R; Briones, A M; Salaices, M; Alonso, M J.
Afiliación
  • Hernanz R; Dept. of Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
  • Martínez-Revelles S; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Palacios R; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Martín A; Dept. of Farmacología, Universidad Autónoma de Madrid, Madrid, Spain.
  • Cachofeiro V; Dept. of Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
  • Aguado A; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • García-Redondo L; Dept. of Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
  • Barrús MT; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • de Batista PR; Dept. of Fisiología, Universidad Complutense de Madrid, Madrid, Spain.
  • Briones AM; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Salaices M; Dept. of Farmacología, Universidad Autónoma de Madrid, Madrid, Spain.
  • Alonso MJ; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Br J Pharmacol ; 172(12): 3159-76, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25712370
ABSTRACT
BACKGROUND AND

PURPOSE:

Toll-like receptor 4 (TLR4) signalling contributes to inflammatory cardiovascular diseases, but its role in hypertension and the associated vascular damage is not known. We investigated whether TLR4 activation contributed to angiotensin II (AngII)-induced hypertension and the associated vascular structural, mechanical and functional alterations. EXPERIMENTAL

APPROACH:

AngII was infused (1.44 mg · kg(-1) · day(-1), s.c.) for 2 weeks in C57BL6 mice, treated with a neutralizing anti-TLR4 antibody or IgG (1 µg · day(-1); systolic BP (SBP) and aortic cytokine levels were measured. Structural, mechanical and contractile properties of aortic and mesenteric arterial segments were measured with myography and histology. RT-PCR and Western blotting were used to analyse these tissues and cultured vascular smooth muscle cells (VSMC) from hypertensive rats (SHR). KEY

RESULTS:

Aortic TLR4 mRNA levels were raised by AngII infusion. Anti-TLR4 antibody treatment of AngII-treated mice normalised (i) increased SBP and TNF-α, IL-6 and CCL2 levels; (ii) vascular structural and mechanical changes; (iii) altered aortic phenylephrine- and ACh-induced responses; (iv) increased NOX-1 mRNA levels, superoxide anion production and NAD(P)H oxidase activity and effects of catalase, apocynin, ML-171 and Mito-TEMPO on vascular responses; and (v) reduced NO release and effects of L-NAME on phenylephrine-induced contraction. In VSMC, the MyD88 inhibitor ST-2825 reduced AngII-induced NAD(P)H oxidase activity. The TLR4 inhibitor CLI-095 reduced AngII-induced increased phospho-JNK1/2 and p65 NF-κB subunit nuclear protein expression. CONCLUSIONS AND IMPLICATIONS TLR4 up-regulation by AngII contributed to the inflammation, endothelial dysfunction, vascular remodelling and stiffness associated with hypertension by mechanisms involving oxidative stress. MyD88-dependent activation and JNK/NF-κB signalling pathways participated in these alterations.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Angiotensina II / Receptor Toll-Like 4 / Remodelación Vascular / Hipertensión Idioma: En Revista: Br J Pharmacol Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Angiotensina II / Receptor Toll-Like 4 / Remodelación Vascular / Hipertensión Idioma: En Revista: Br J Pharmacol Año: 2015 Tipo del documento: Article